ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000235423.4	Serdemetan	Breast invasive carcinoma	0.046756314	Resistant
ENSG00000235423.4	Serdemetan	Chronic Lymphocytic Leukemia	0.004755594	Resistant